Monocytic parameters in patients with dysthymia versus major depression

Journal of Affective Disorders

Volumn 78, Issue 3, 2004, Pages 243-247

  Schlatter, Javier ^a   Ortuño, Felipe ^a   Cervera Enguix, Salvador ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Cytokines; Depression; Dysthymia; Monocyte; Phagocytosis; Respiratory burst

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; HLA ANTIGEN CLASS 2; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSTHYMIA; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MOLECULE; MONOCYTE; MOOD DISORDER; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST;

EID: 0842287484     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(02)00316-6     Document Type: Article

References (25)

1. Anisman H., Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. Adv. Exp. Med. Biol. 461:1999;199-233.
2. Anisman H., Ravindran A.V., Griffiths J., Merali Z. IL-1β production in dysthymia before and after pharmacotherapy. Biol. Psychiatry. 46:1999;1649-1655.
3. Brambilla F., Maggioni M. Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr. Scand. 97:1998;309-313.
4. Cervera-Enguix S., Rodríguez-Rosado A. Depression and monocyte dysfunction: a follow-up study. Eur. Psychiatry. 9:1994;293-298.
5. Guy W. ECDEU Assessment Manual for Psychopharmacology. 1976;NIMH, Psychopharmacology Research Branch, Bethesda, MD.
6. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 6:1959;278-296.
7. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6:1967;278-298.
8. Irwin M. Depression and immunity. Ader R., Felten D.L., Cohen N. Psychoneuroimmunology. Vol. 2:2001;383-398 Academic Press, San Diego.
9. Landmann R., Schaub B., Link S., Wacker H.R. Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy. Biol. Psychiatry. 41:1997;675-681.
10. Lanquillon S., Krieg J.C., Bening-Abu-Shah U., Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 22:(4):2000;370-379.
11. Maes M. Interleukin-1β and the etiology of depression. Acta Psychiatr. Scand. 103:2001;161-162.
12. Maes M., Smith R., Scharpe S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology. 2:1995;111-116.
13. Maes M., Bosmans E., Meltzer H.Y., Scharpé S., Suy E. Interleukin-1β: a putative mediator of HPA axis hyperactivity in major depression? Am. J. Psychiatry. 150:1993;1189-1193.
14. Maes M., Van der Planken M., Stevens W.J., Peeters D., De Clerck L.S., Bridts C.H., Schotte C., Cosyns P. Leukocytosis, monocytosis and neutrophilia: hallmarks of severe depression. J. Psychiatr. Res. 26:(2):1992;125-134.
15. McAdams C., Leonard B.E. Neutrophil and monocyte phagocytosis in depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry. 17:(6):1993;971-984.
16. Natelson B.H., Denny T., Zhou X.D., LaManca J.J., Ottenweller J.E., Tiersky L., DeLuca J., Gause W.C. Is depression associated with immune activation? J. Affect. Disord. 53:1999;179-184.
17. Owen B.M., Eccleston D., Ferrier I.N., Young A.H. Raised levels of plasma interleukin-1β in major and postviral depression. Acta Psychiatr. Scand. 103:2001;226-228.
18. Ravindran A.V., Griffiths J., Merali Z., Anisman H. Lymphocyte subsets associated with major depression and dysthymia: modification by antidepressant treatment. Psychosom. Med. 57:(6):1995;555-563.
19. Rothermundt M., Arolt V., Peters M., Gutbrodt H., Fenker J., Kersting A., Kirchner H. Inflammatory markers in major depression and melancholia. J. Affect. Disord. 63:2001;93-102.
20. Schlatter J., Ortuño F., Cervera S. Differences interleukine's patterns between dysthymia and major depression. Eur. Psychiatry. 16:2001;317-319.
21. Seidel A., Arolt V., Hunstiger M., Rink L., Behnisch A., Kirchner H. Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr. Scand. 94:1996;198-204.
22. Sluzewska A., Rybakowski J.K., Bosmans E., Sobieska M., Berghmans R., Maes M., Wiktorowicz K. Indicators of immune activation in major depression. Psychiatry Res. 64:1996;161-167.
23. Song C., Kenis G., Van Gastel A., Bosmans E., Lin A., De Jong R., Neels H., Scharpé S., Janca A., Yasukawa K., Maes M. Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes. Psychiatry Res. 85:1999;293-303.
24. Weizman R., Laor N., Podliszewski E., Notti I., Djaldetti M., Bessler H. Cytokine production in major depressed patients before and after clomipramine treatment. Biol. Psychiatry. 35:1994;42-47.
25. Zaharia M.D., Ravindran A.V., Griffiths J., Merali Z., Anisman H. Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features. J. Affect. Disord. 58:(1):2000;1-10.